Tag

Oppenheimer

All articles tagged with #oppenheimer

Michael Biopic Tops Oppenheimer to Set New Box-Office Benchmark
entertainment13 days ago

Michael Biopic Tops Oppenheimer to Set New Box-Office Benchmark

Two months into its release, Lionsgate/Universal's Michael has become the highest-grossing biopic ever with $977.4 million worldwide, surpassing Oppenheimer's $965 million. The film opened with a record $217 million worldwide and has since posted strong domestic and international grosses, including about $370 million domestic. With the global total nearing $1 billion and a planned sequel (and potential re-release), it could become the first biopic to reach $1 billion worldwide.

Michael Biopic Tops Oppenheimer as All-Time Highest-Grossing Biopic
box-office13 days ago

Michael Biopic Tops Oppenheimer as All-Time Highest-Grossing Biopic

Lionsgate’s Michael, starring Jafar Jackson, has overtaken Oppenheimer to become the highest-grossing biopic ever, with $977.4 million worldwide after its tenth weekend. Oppenheimer sits at $975.8 million, aided by a late Japan release. Michael is at about $370.2 million domestic and $607.2 million foreign, and could reach $1 billion worldwide. The film’s run also highlights a shorter PVOD window (46 days) compared with Oppenheimer’s longer theatrical-to-PVOD timeframe.

Michael Biopic Tops Oppenheimer, Sets All-Time Biopic Box-Office Record
entertainment13 days ago

Michael Biopic Tops Oppenheimer, Sets All-Time Biopic Box-Office Record

The Michael biopic has grossed $977 million worldwide, surpassing Christopher Nolan’s Oppenheimer ($975M) to become the highest-grossing biopic of all time and the top musical biopic, with about $607.2 million overseas and $370.2 million domestically since April. It opened to $97 million domestically and $217 million globally, and Lionsgate says the marketing focus on real-life performances and Jackson re-creations helped drive the record, with potential for more Jackson-life projects.

Nolan’s Odyssey Sets Sights on an $80M-$100M U.S. Opening
box-office13 days ago

Nolan’s Odyssey Sets Sights on an $80M-$100M U.S. Opening

Christopher Nolan’s The Odyssey is tracking for an $80-100 million domestic debut, driven by strong advance sales on IMAX and premium formats. With Nolan’s film serving as the sole major wide release that weekend and a three-week IMAX exclusive run, early indicators point to blockbuster potential and solid legs, echoing the buzz that followed Oppenheimer.

Nolan Says The Odyssey Will Be Epic, But Shorter Than Oppenheimer
entertainment2 months ago

Nolan Says The Odyssey Will Be Epic, But Shorter Than Oppenheimer

Christopher Nolan says The Odyssey will be an epic but shorter than Oppenheimer, which ran 180 minutes. While the exact runtime and rating for The Odyssey haven’t been announced, the Universal Pictures release opens July 17. The film, shot entirely with IMAX cameras and featuring a star-studded cast (including Matt Damon and Tom Holland), is noted for its massive production scale and a new IMAX blimp to reduce camera noise for dialogue-heavy scenes.

Gosling’s Project Hail Mary Rockets to $53M Weekend as Horror Struggles
entertainment3 months ago

Gosling’s Project Hail Mary Rockets to $53M Weekend as Horror Struggles

Ryan Gosling’s sci‑fi Project Hail Mary dominates the weekend box office with a projected $53.1 million domestic hold and a global total well over $200 million, following an $80.6 million opening; the horror‑comedy They Will Kill You underperforms and is unlikely to reach $5 million, as franchise chatter grows around Hail Mary.

Nvidia Eyes AI-Driven Upside Ahead of Q4 Earnings
business4 months ago

Nvidia Eyes AI-Driven Upside Ahead of Q4 Earnings

NVDA is expected to see a typical $2–3 billion upside to Q4 FY26 and Q1 FY27 sales, supporting a Buy rating and a $265 price target (roughly 40% upside). The company is projected to post about $65.6 billion in Q4 revenue and $1.52 EPS as AI demand accelerates, GB300 Ultra drives growth, and cloud capex rises; with China now included, Nvidia’s total addressable market could approach $4 trillion, underscoring its leadership in AI platforms.

Analysts Forecast Major Stock Gains in 2025
finance1 year ago

Analysts Forecast Major Stock Gains in 2025

Oppenheimer's chief investment strategist, John Stoltzfus, predicts continued market growth into 2025, with the S&P 500 potentially reaching 7100. The firm highlights two 'Strong Buy' stocks with significant growth potential: Sagimet Biosciences and Y-mAbs Therapeutics. Sagimet is advancing its fatty acid synthase inhibitors for conditions like MASH and acne, while Y-mAbs is developing its SADA platform for targeted cancer therapies. Both companies have received positive analyst ratings, with Sagimet potentially seeing a 583% increase and Y-mAbs a 144% rise.